Can Boohoo.Com PLC (+73%), Randgold Resources Limited (+81%) And NMC Health PLC (+69%) Keep On Soaring?

Are rises at Boohoo.Com PLC (LON: BOO), Randgold Resources Limited (LON: RRS) and NMC Health PLC (LON: NMC) sustainable?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

From their 12-month low in May 2015, shares in boohoo.com (LSE: BOO) have climbed by 73% to 44p, but is more to come? More traditional clothing stores like Marks & Spencer are struggling (M&S’s Q4 performance in clothing was “unsatisfactory“). But online vendors are doing much better than I’d expected — I might be old-fashioned, but I always thought touch and feel was an essential part of the transaction.

Results from boohoo should be with us on 26 April and should be good with analysts expecting a 46% rise in EPS. They have further gains above 20% per year pencilled-in for the next two years. But one thing that still leaves me wary is the volatility of the share price — since floatation in March 2014, the shares are actually down 39%. I’m also keenly aware of the ups and downs that ASOS shareholders have faced. Over five years those shares are up 62%, yet if you’d been unlucky enough to buy at their peak in February 2014, you’d be down 53%.

There’s a bit of a “dotcom bubble” feel about boohoo (and ASOS) to me, with boohoo shares on a forward P/E of 25 as far out as February 2018 (though it’s a lot lower than the multiple of 47 for ASOS based on August 2017 forecasts), and that puts me right off. But I’m an old bloke and I buy my shares the way I buy my clothes — conventional stuff that I intend to keep for years — so what do I know?

Shiny shiny

If you’d bought Randgold Resources (LSE: RRS) at their low point in September 2015, you’d be sitting on a nice gain of 81% right now as the shares have reached 6600p. That’s on the back of the rising price of gold, which has reached the $1,200 level per ounce from only a little over $1,000 in December.

Buying mining shares is a good way of gearing up the profits you can make over buying the metal itself — every percentage rise in the price of gold represents a bigger percentage rise in a miner’s profits once it has cleared the cost of production. Of course, the same works in reverse and a gold price fall is geared up to a bigger percentage fall in miners’ profits.

What I don’t like about Randgold shares is their high forward P/E of 37, dropping only as far as 31 on 2017 forecasts, because that suggests there’s a fair bit more gold price growth built into the share price. I reckon trying to guess where something as fundamentally useless as gold is going is a waste of time.

Health profits

NMC Health (LSE: NMC) has been a growth star, with a 69% rise since last April’s peak to 1120p, and a 390% gain over five years. And for once, I’m seeing a growth share that I actually like the look of. NMC operates a healthcare chain in the United Arab Emirates, where oil wealth has produced plenty of customers who want top medical treatment — as shown in several years of accelerating earnings growth.

What’s more, we have an EPS rise of 58% forecast this year, followed by 23% next, and that would drop the P/E to just 16. We’re also looking at PEG ratios (which compare the P/E with the growth rate, the lower the better) of 0.3 this year and 0.7 next — and that’s firmly in the territory that would have excited the growth investor in a younger me.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended ASOS. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »